Loading provider…
Loading provider…
Dermatology Physician in Northridge, CA
NPI: 1730177932Primary Employer
Lawrence Osman MD PC
drosman.com
HQ Phone
Get MD Lawrence's Phone Numberphone_androidMobile
Get MD Lawrence's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2002 - 2026

American Board of Dermatology
Dermatology
University at Buffalo
Residency • Dermatology
1999 - 2002
University of California (San Francisco)/Fresno
Internship • Internal Medicine
1998 - 1999
Keck School of Medicine of USC
keck.usc.edu
Medical School
Until 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99212Established patient outpatient visit, total time 10-19 minutes | 447 | 675 |
| 2 | 17000Destruction of skin growth | 347 | 566 |
| 3 | 88305Pathology examination of tissue using a microscope, intermediate complexity | 317 | 484 |
| 4 | 11102Tangential biopsy of single skin lesion | 298 | 343 |
| 5 | 17003Destruction of 2-14 skin growths | 273 | 2,163 |
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial ...
Authors: Brett King, Maryanne M Senna, Natasha A Mesinkovska, Charles Lynde, Matthew Zirwas
Authors: Maryanne Senna, Sameh Hanna, Natasha Mesinkovska, Nathaniel Cevasco
Journal: J Am Acad Dermatol
Publication Date: 2024-07-23
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib
Lead Sponsor: Orlucent, Inc
Intervention / Treatment: OTHER: Diagnostic Test
Lead Sponsor: LEO Pharma
Intervention / Treatment: DRUG: Tralokinumab